Search of published and open access research on microarray, sequencing and proteomic expression analysis did not uncover any datasets to ascertain at a preliminary level whether TMEM230 was differentially expressed specifically between non-malignant glial cells and glial cells from low- or high-grade gliomas. This evidence concerns the gene TMEM230 and glioma.